for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Yunnan Baiyao Group Co., Ltd

000538.SZ

Latest Trade

77.60CNY

Change

0.18(+0.23%)

Volume

5,146,744

Today's Range

77.05

 - 

78.18

52 Week Range

68.50

 - 

98.88

As of on the Shenzhen Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
77.42
Open
77.50
Volume
5,146,744
3M AVG Volume
84.55
Today's High
78.18
Today's Low
77.05
52 Week High
98.88
52 Week Low
68.50
Shares Out (MIL)
1,277.40
Market Cap (MIL)
98,896.56
Forward P/E
22.78
Dividend (Yield %)
2.58

Latest Developments

More

Yunnan Baiyao's H1 Net Profit Up 8.6% Y/Y

Yunnan Baiyao Group Elects Wang Minghui As Chairman

Yunnan Baiyao Says Ping An Life Insurance To Trim Stake In The Company

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Yunnan Baiyao Group Co., Ltd

YUNNAN BAIYAO GROUP CO.,LTD is a China-based company principally engaged in the research, development, manufacture and operation of pharmaceuticals, as well as the wholesaling and retailing of purchased pharmaceuticals. The Company’s products are categorized into traditional Chinese medicine resources, Chinese and western raw medicine materials and preparations, personal care products and raw materials, with Yunnan Baiyao band-aids, Yunnan Baiyao aerosol and Yunnan Baiyao ointment as its main effective products. The Company also provides skin care products and health care products. The Company distributes its products within domestic market and to overseas markets, with domestic market as its main market.

Industry

Retail (Drugs)

Contact Info

222 Er' huan Xi Road

+86.871.66324159

http://overseasdivision.yunnanbaiyao.com.cn

Executive Leadership

Minghui Wang

Chairman of the Board

Wei Wu

Chief Financial Officer, Secretary of the Board

Jin Li

Chief Technology and Quality Officer

Pinyao Yin

General Manager, Director

Wanmin Qin

Deputy General Manager

Key Stats

1.64 mean rating - 11 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2016

22.4K

2017

24.3K

2018

26.7K

2019(E)

29.0K
EPS (CNY)

2016

2.800

2017

3.020

2018

3.175

2019(E)

3.408
Price To Earnings (TTM)
20.56
Price To Sales (TTM)
3.58
Price To Book (MRQ)
2.25
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
7.07
LT Debt To Equity (MRQ)
0.01
Return on Investment (TTM)
13.35
Return on Equity (TTM)
10.11

Latest News

BRIEF-Yunnan Baiyao Group unit to set up drug sales JV with partner

* Says its wholly owned pharmaceutical unit plans to set up a drug sales JV with partner, with registered capital of 10 million yuan

BRIEF-Pharmaceutical firm Yunnan Baiyao's Q3 net profit up 7.0 percent y/y

Yunnan Baiyao Group Co Ltd * Says Q3 net profit up 7.0 percent y/y Source text in Chinese: http://bit.ly/2yWlnf1 Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-Yunnan Baiyao Group announces change in accounting policy

* Says it changes accounting policy based on accounting standards for business enterprises

BRIEF-Pharmaceutical firm Yunnan Baiyao's H1 net profit up 12.75 pct y/y

Yunnan Baiyao Group Co Ltd * Says H1 net profit up 12.75 percent y/y Source text in Chinese: http://bit.ly/2wxdzzB Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-Yunnan Baiyao Group says 2016 dividend payment date on July 18

* Says it will pay a cash dividend of 8 yuan per 10 shares(before tax) for 2016 to shareholders of record on July 17

BRIEF-Yunnan Baiyao's Q1 net profit up 16.6 percent y/y

* Says Q1 net profit up 16.6 percent y/y at 725.1 million yuan ($105.16 million)

BRIEF-Yunnan Baiyao's shares to resume trade on April 27

* Says shares to resume trading on April 27 after Yunnan Baiyao Holdings completed acquisition

BRIEF-Yunnan Baiyao Group to pay cash div 8 yuan per 10 shares for FY 2016

* Says it plans to pay cash div 8 yuan per 10 shares for FY 2016

BRIEF-Yunnan Baiyao Group's 2016 profit up, sets 2017 operating income target

* Says 2016 net profit up 5.4 percent y/y at 2.9 billion yuan ($421.24 million)

BRIEF-Yunnan Baiyao Holdings offers to buy Yunnan Baiyao Group's shares for 39.6 bln yuan

* Says shareholder changes in Yunnan Baiyao Holdings after Newhuadu Industrial Group's investment

BRIEF-China's anti-monopoly bureau approves NewHuadu's investment in Yunnan Baiyao's controlling shareholder

* Says China's anti-monopoly bureau approves NewHuadu Industrial Group's investment in company's controlling shareholder

BRIEF-Yunnan Baiyao Group's Q3 net profit up 9.6 pct

Further company coverage: (Reporting by Hong Kong newsroom)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up